Trial intelligence / Profile preview

Lactobacillus casei Shirota for respiratory infections in elderly

NCT00849277Phase 4Completed

Sponsor
University of Antwerp
Start
Oct 2006
Primary completion
Apr 2008
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 4 trial of lacticaseibacillus casei shirota in respiratory tract infection (RTI), sponsored by University of Antwerp. Started Oct 2006; status: completed.

02

Drugs

lacticaseibacillus casei shirota
03

Conditions

respiratory tract infection (RTI)

Beyond the preview

Go deeper on NCT00849277.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00849277.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call